Delivery Order SPE2DB22D1106-SPE2DB24FESW8

Award Date 5/21/24
Potential Completion Date 5/22/24
Potential Value $4.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,180.98, is for the delivery of GLYCOPYRROLATE 0.2 MG/ML VIAL 2ML, a medication commonly used to treat certain medical conditions. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,734.86 firm fixed-price delivery order is for the supply of glycopyrrolate 0.2 mg/mL vials to support military healthcare programs. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,157.14 firm fixed-price delivery order is for the supply of 4 mg/20 ml vials of the medication glycopyrrolate. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA to provide a comprehensive range of pharmaceutical products and medical supplies supporting...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,025.07 delivery order is for the supply of 4 mg/20 ml vials of the drug glycopyrrolate, a medication used to treat various conditions. The contract is a Firm Fixed Price Delivery Order with a completion date of September 11, 2024. Amerisourcebergen, through its Corporate Office division, will provide these pharmaceutical products to support...
This federal contract award, valued at $2,090.78, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567362924 ! GLYCOPYRROLATE 1 MG/5 ML VIAL 5ML, a pharmaceutical product. This contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $6,950.54, is for the delivery of 4565120442 - GLYCOPYRROLATE 0.2 MG/ML VIAL 2ML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of July 12, 2024. This award is a delivery order under a larger Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,172.19 delivery order is for the supply of Glycopyrrolate 0.2 mg/ml vials, a medication used to manage certain medical conditions. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This $999,999,999 IDC serves as the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,910.85 firm fixed-price contract is for the supply of GLYCOPYRROLATE 0.2 MG/ML medication, a critical pharmaceutical product used in medical treatment. The contract has an ultimate completion date of December 10, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This is a delivery order federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of Glycopyrrolate 1 mg/5 ml vials, a medication used for various medical treatments. The contract has a ceiling value of $1,160.22 and runs through January 16, 2025. It is a firm fixed-price contract, with no set-aside designation. AmerisourceBergen holds a significant...
This is a federal contract award issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,476.75 delivery order contract is for the supply of GLYCOPYRROLATE 4 MG/20 ML VIAL 20ML, a pharmaceutical product. The contract has an ultimate completion date of October 26, 2023 and is a Firm Fixed Price contract. Amerisourcebergen Drug Corp is the prime contractor, and there is no...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FESW8
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,845.60 firm-fixed-price delivery order is for the supply of glycopyrrolate 1 mg/5 ml vials, a medication used to treat certain conditions.

The award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition.

Generated 5/16/25, 12:26 PM